Tamtam Try Tamtam free
Maastricht UMC+ logo

Maastricht UMC+ account plan

Patient-centered healthcare services

At a glance

Maastricht UMC+ is the Dutch academic medical centre of azM and Maastricht University: EUR 1,230 mln revenue and 7,125 employees in 2025.

Maastricht UMC+ is the partnership between the academic hospital azM (academisch ziekenhuis Maastricht) and the Faculty of Health, Medicine and Life Sciences of Maastricht University. It provides top-referral and top-clinical care, research, education and valorisation, plus basic hospital care for Maastricht and its surroundings, and is one of the largest employers in South Limburg. In 2025 consolidated revenue was EUR 1,230 mln (EUR 1,171 mln in 2024) and the consolidated result fell to EUR 6.5 mln from EUR 22.0 mln. It had 7,125 employees (5,412 FTE), 546 beds and 16 operating theatres, with 24,048 admissions. The azM is a public-law entity governed by an Executive Board chaired by Helen Mertens and a Supervisory Board chaired by Roger Dassen.

Business units

Strategic priorities

National centre for prevention and vitality
Under the strategy Gezond Leven 2025 - nader ingekleurd, MUMC+ aims to become the national knowledge and expertise centre for prevention and vitality, with the ambition to be the national centre for prevention, lifestyle and vitality in 2030.
Stronger academic profile (Briljant)
The Briljant programme, started in 2025, aims to attract more academic patients and move non-academic care to SJG Weert and Annadal Kliniek.
Care of the future
A strategic programme on data-driven work, digitalisation, AI and hybrid care such as 24/7 monitoring on wards and home monitoring; the strategy is being renewed in 2026 around sustainability, climate, data, AI, quality of life and vitality.
Culture and social safety
After a BCG culture study in which over 4,000 staff took part, the programme Veiligheid, duidelijkheid en vertrouwen started and an improvement plan has been carried out since early 2026.
Sustainability targets
55% CO2 reduction by 2030 versus 2015 and 95% by 2050, and halving primary raw-material use by 2030.
Cooperation with Maastricht University
Employee councils voted against administrative integration, so the integration plan is being reconsidered in 2026 and the CEO is looking for another governance model.

Investments and deals

Building programme 2026-2040
A new entrance building and thorough renovation of the bed tower, wards and outpatient clinics; the CEO puts the total at EUR 600 mln, the Supervisory Board at EUR 500 mln in the coming years, and the annual report at about EUR 40 mln a year. Work on the entrance building starts in 2026 and a EUR 200 mln financing request for 2027-2029 is being prepared.
New ERP system
A new ERP for procurement, logistics and finance was awarded to Delaware/SAP in autumn 2025, with implementation from early 2026 to H1 2027 (indicative EUR 12 mln).
Epic EHR and ICT
The Epic EHR has been live since November 2024; ICT investment runs at about EUR 7.3 mln a year for storage, telecom and network.
Medical equipment
About EUR 13 mln a year, mostly replacements; two Da Vinci 5 robots and a Hugo robot system followed in 2026.

Challenges and risks

Cuts to academic funding
Planned cuts to the BBAZ academic-care contribution and specialist-training funds from 2029 are a major financial threat, and measures are already needed in 2026.
Thin financial result
Costs rose EUR 65 mln against EUR 46.2 mln more revenue in 2025, driven by collective-agreement effects, more FTE, medicine costs and Epic licence and capital charges.
Staff shortages
Staff shortages and organisational agility are a top strategic risk; there were 498 vacancies during 2025 and scarce professions remain hard to fill.
Information and data security
Availability, integrity, confidentiality and sovereignty of data are a strategic risk, including less dependence on big tech.
Rising care demand
Rising care demand and dilution of the academic profile are among the six strategic top risks re-assessed in 2025.

What leadership says

“We knew that the relatively high results of the years before were not structural. We did not count ourselves rich on them.”

Helen Mertens, Chair of the Executive Board (CEO) · News release on the 2025 annual report, 26 May 2026 (translated from Dutch)

“Despite the still tight labour market, we currently succeed faster in filling our open vacancies.”

Helen Mertens, Chair of the Executive Board (CEO) · News release on the 2025 annual report, 26 May 2026 (translated from Dutch)

“At the same time everyone recognises the need for far-reaching cooperation, to seize growth opportunities and stand up to threats. Together we can increase our contribution to society; separately we are more vulnerable.”

Helen Mertens, Chair of the Executive Board (CEO) · On integration with Maastricht University, news release of 26 May 2026 (translated from Dutch)

Where a supplier can help

ERP implementation support
Tied to the Delaware/SAP ERP rollout from early 2026 to H1 2027: procurement, logistics and finance process, data migration and training partners.
Construction and renovation supply
Tied to the 2026-2040 building programme: contractors, medical furnishing and equipment suppliers for the entrance building, bed tower and outpatient clinics.
Cost and result improvement
Tied to the thin financial result and the funding cuts: suppliers that lower medicine, licence or operating costs fit the result-improvement initiatives built into 2026 budgets.
Recruitment and workforce tools
Tied to the staff-shortage risk: recruitment, scheduling and retention solutions for scarce professions.
Hybrid care and data security
Tied to the care-of-the-future programme and the data-security risk: remote monitoring, AI and sovereign data solutions.

Tamtam's reading of the priorities and challenges above, not the company's own words.

Selling to companies like Maastricht UMC+?

Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.

Find similar companies

Key documents

Read in full by Tamtam; each summary links to the document itself.

Questions about Maastricht UMC+

What is Maastricht UMC+?

It is the partnership between the academic hospital azM and the Faculty of Health, Medicine and Life Sciences of Maastricht University, providing top-referral care, research, education and basic hospital care for the Maastricht region.

What is Maastricht UMC+'s revenue?

Consolidated revenue was EUR 1,230 mln in 2025 (EUR 1,171 mln in 2024), with a consolidated result of EUR 6.5 mln.

How many people work at Maastricht UMC+?

7,125 employees, or 5,412 FTE, at the end of 2025.

Who leads Maastricht UMC+?

Helen Mertens chairs the Executive Board, with Veronique Thoelen as acting CFO after Gabriel Zwart left in December 2025; Roger Dassen chairs the Supervisory Board.

What is Maastricht UMC+'s strategy?

To become the national knowledge and expertise centre for prevention and vitality and strengthen its academic profile, notably by moving non-academic care to its subsidiaries under the Briljant programme.

Written by Tamtam from the company's own published documents listed above, read in full. Figures are as those documents state them, for the periods they name. (2026-11-17)